{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:18:46Z","timestamp":1790867926369,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1989]]},"DOI":"10.1007\/bf00558227","type":"journal-article","created":{"date-parts":[[2004,11,20]],"date-time":"2004-11-20T10:53:59Z","timestamp":1100948039000},"page":"173-180","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome"],"prefix":"10.1007","volume":"37","author":[{"given":"P. A.","family":"Sj\ufffdstr\ufffdm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. G.","family":"Odlind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Beermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. E.","family":"Karlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00003495-198530050-00003","volume":"30","author":"DC Brater","year":"1985","unstructured":"Brater DC (1985) Resistance to loop diuretics. Why it happens and what to do about it. Drugs 30: 427?443","journal-title":"Drugs"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/clpt.1980.111","volume":"27","author":"B Odlind","year":"1980","unstructured":"Odlind B, Beermann B (1980) Renal tubular secretion and effects of furosemide. Clin Pharmacol Ther 27: 784?790","journal-title":"Clin Pharmacol Ther"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ki.1982.134","volume":"22","author":"S Kaojarern","year":"1982","unstructured":"Kaojarern S, Day B, Brater DC (1982) The time course of delivery of furosemide into urine: An independent determinant of overall response. Kidney Int 22: 69?74","journal-title":"Kidney Int"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cpt1978242199","volume":"24","author":"A Rane","year":"1978","unstructured":"Rane A, Villeneuve JP, Stone WJ, Nies AS, Wilkinson GR, Branch RA (1978) Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia. Clin Pharmacol Ther 24: 199?207","journal-title":"Clin Pharmacol Ther"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1203\/00006450-198302000-00012","volume":"17","author":"J Prandota","year":"1983","unstructured":"Prandota J (1983) Pharmacokinetics of furosemide urinary elimination by nephrotic children. Pediatr Res 17: 141?147","journal-title":"Pediatr Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/clpt.1982.187","volume":"32","author":"E Keller","year":"1982","unstructured":"Keller E, Hoppe-Seyler G, Schollmeyer P (1982) Disposition and diuretic effect of furosemide in the nephrotic syndrome. Clin Pharmacol Ther 32: 442?449","journal-title":"Clin Pharmacol Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jps.2600740604","volume":"74","author":"DE Smith","year":"1985","unstructured":"Smith DE, Hyneck ML, Berardi RR, Port FK (1985) Urinary protein binding, kinetics, and dynamics of furosemide in nephrotic patients. J Pharm Sci 74: 603?607","journal-title":"J Pharm Sci"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0024-3205(80)90238-6","volume":"26","author":"TP Green","year":"1980","unstructured":"Green TP, Mirkin BL (1980) Resistance of proteinuric rats to furosemide: urinary drug protein binding as a determinant of drug effect. Life Sci 26: 623?630","journal-title":"Life Sci"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1172\/JCI102935","volume":"33","author":"HA Eder","year":"1954","unstructured":"Eder HA, Lauson HD, Chinard FP, Greif RI, Cotzias GC, van Slyke DD (1954) A study of the mechanisms of edema formation in patients with the nephrotic syndrome. J Clin Invest 33: 636?656","journal-title":"J Clin Invest"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000409944","volume":"43","author":"EJ Dorhout Mees","year":"1984","unstructured":"Dorhout Mees EJ (1984) Edema formation in the nephrotic syndrome. Contrib Nephrol 43: 64?75","journal-title":"Contrib Nephrol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000183392","volume":"39","author":"EA Brown","year":"1985","unstructured":"Brown EA, Markandu ND, Sagnella GA, Jones BE, MacGregor GA (1985) Sodium retention in the nephrotic syndrome is due to an intrarenal defect: Evidence from steroid-induced remission. Nephron 39: 290?295","journal-title":"Nephron"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000184486","volume":"47","author":"HA Koomans","year":"1987","unstructured":"Koomans HA, Boer WH, Dorhout Mees EJ (1987) Renal function during recovery from minimal lesions nephrotic syndrome. Nephron 47: 173?178","journal-title":"Nephron"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9343(79)90782-4","volume":"67","author":"EJ Dorhout Mees","year":"1979","unstructured":"Dorhout Mees EJ, Roos JC, Boer P, Yoe OH, Simatupang TA (1979) Observations on edema formation in nephrotic syndrome in adults with minimal lesions. Am J Med 67: 378?384","journal-title":"Am J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ki.1984.176","volume":"26","author":"AB Geers","year":"1984","unstructured":"Geers AB, Koomans HA, Roos JC, Boer P, Dorhout Mees EJ (1984) Functional relationships in the nephrotic syndrome. Kidney Int 26: 324?330","journal-title":"Kidney Int"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000166814","volume":"4","author":"HA Koomans","year":"1984","unstructured":"Koomans HA, Geers AB, van der Meiracker AH, Roos JC, Boer P, Dorhout Mees EJ (1984) Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome. Am J Nephrol 4: 227?234","journal-title":"Am J Nephrol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0140-6736(82)90102-7","volume":"2","author":"EA Brown","year":"1982","unstructured":"Brown EA, Markandu ND, Sagnella GA, Squires M, Jones BE, MacGregor GA (1982) Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. Lancet 2: 1237?1240","journal-title":"Lancet"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000183206","volume":"37","author":"EA Brown","year":"1984","unstructured":"Brown EA, Markandu ND, Sagnella GA, Jones BE, MacGregor GA (1984) Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Nephron 37: 43?48","journal-title":"Nephron"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-9343(77)90541-1","volume":"63","author":"AM Chonko","year":"1977","unstructured":"Chonko AM, Bay WH, Stein JH, Ferris TF (1977) The role of renin and aldosterone in the salt retention of edema. Am J Med 63: 881?889","journal-title":"Am J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI110756","volume":"71","author":"HG Ichikawa","year":"1983","unstructured":"Ichikawa HG, Rennke HG, Hoyer JR, Badr KF, Schor N, Troy JL, Lechene CP, Brenner BM (1983) Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 71: 91?103","journal-title":"J Clin Invest"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00630286","volume":"26","author":"MM Hammarlund","year":"1984","unstructured":"Hammarlund MM, Paalzow LK, Odlind B (1984) Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis. Eur J Clin Pharmacol 26: 197?207","journal-title":"Eur J Clin Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/jcem-38-4-622","volume":"38","author":"JK McKenzie","year":"1974","unstructured":"McKenzie JK, Clements JA (1974) Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol Metab 38: 622?627","journal-title":"J Clin Endocrinol Metab"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/BF01473295","volume":"33","author":"J F\u00fchr","year":"1955","unstructured":"F\u00fchr J, Kaczmarczyk J, Kr\u00fcttgen C-D (1955) Eine einfache colorimetrische Methode zur Inulinbestimmung f\u00fcr Nieren-Clearanceuntersuchungen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr 33: 729?730","journal-title":"Klin Wochenschr"},{"key":"CR23","first-page":"955","volume":"37","author":"C Brun","year":"1951","unstructured":"Brun C (1951) A rapid method for the determination of paraaminohippuric acid in kidney function test. J Lab Clin Med 37: 955?958","journal-title":"J Lab Clin Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2165\/00003088-198005060-00005","volume":"5","author":"C Allgulander","year":"1980","unstructured":"Allgulander C, Beermann B, Sj\u00f6gren A (1980) Frusemide pharmacokinetics in patients with liver disease. Clin Pharmacokinet 5: 570?575","journal-title":"Clin Pharmacokinet"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0773.1974.tb00724.x","volume":"35","author":"F Andreasen","year":"1974","unstructured":"Andreasen F, Jakobsen P (1974) Determination of furosemide in blood plasma and its binding to proteins in normal plasma and in plasma from patients with acute renal failure. Acta Pharmacol Toxicol 35: 49?57","journal-title":"Acta Pharmacol Toxicol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4613-2067-8_24","volume-title":"Diuretics: Basic pharmacological, and clinical aspects","author":"P Sj\u00f6str\u00f6m","year":"1987","unstructured":"Sj\u00f6str\u00f6m P, Odlind B, Beermann B, Hammarlund-Udenaes M (1987) Changes in furosemide pharmacokinetics induced by dehydration. In: Andreucci VE, Dal Canton A (eds) Diuretics: Basic pharmacological, and clinical aspects. Martinus Nijhoff, Boston, USA, pp 107?109"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1152\/ajplegacy.1975.229.1.93","volume":"229","author":"RH Bowman","year":"1975","unstructured":"Bowman RH (1975) Renal secretion [35S]furosemide and its depression by albumin binding. Am J Physiol 229: 93?98","journal-title":"Am J Physiol"},{"key":"CR28","first-page":"263","volume":"232","author":"S Hall","year":"1985","unstructured":"Hall S, Rowland M (1985) Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney. J Pharmacol Exp Ther 232: 263?268","journal-title":"J Pharmacol Exp Ther"},{"key":"CR29","first-page":"122","volume":"218","author":"TP Green","year":"1981","unstructured":"Green TP, Mirkin BL (1981) Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion. J Pharmacol Exp Ther 218: 122?127","journal-title":"J Pharmacol Exp Ther"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/clpt.1988.177","volume":"44","author":"G Alv\u00e1n","year":"1988","unstructured":"Alv\u00e1n G, Beermann B, Hjelte L, Lind M, Lindholm A, Strandvik B (1988) Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis. Clin Pharmacol Ther 44: 436?441","journal-title":"Clin Pharmacol Ther"},{"key":"CR31","volume-title":"Clinical pharmacokinetics concepts and applications","author":"M Rowland","year":"1980","unstructured":"Rowland M, Tozer T (1980) Clinical pharmacokinetics concepts and applications. Lea and Febiger, Philadelphia"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ki.1987.192","volume":"32","author":"M Inoue","year":"1987","unstructured":"Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y (1987) Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 32: 198?203","journal-title":"Kidney Int"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.0954-6820.1985.tb03255.x","volume":"217","author":"H Danielsen","year":"1985","unstructured":"Danielsen H, Pedersen EB, Madsen M, Jensen T (1985) Abnormal renal sodium excretion in the nephrotic syndrome after furosemide: relation to glomerular filtration rate. Acta Med Scand 217: 513?518","journal-title":"Acta Med Scand"},{"issue":"Suppl 112","key":"CR34","first-page":"13","volume":"24","author":"M Aurell","year":"1969","unstructured":"Aurell M (1969) Renal response in man to plasma volume expansion and angiotensin. Scand J Clin Lab Invest 24 [Suppl 112]: 13?31","journal-title":"Scand J Clin Lab Invest"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1172\/JCI103011","volume":"33","author":"J James","year":"1954","unstructured":"James J, Gordillo G, Metcoff J (1954) Effects of infusion of hyperoncotic dextran in children with the nephrotic syndrome. J Clin Invest 33: 1346?1357","journal-title":"J Clin Invest"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1172\/JCI102314","volume":"29","author":"J Orloff","year":"1950","unstructured":"Orloff J, Welt LG, Stowe L (1950) The effects of concentrated salt-poor albumin on the metabolism and excretion of water and electrolytes in nephrosis and toxemia of pregnancy. J Clin Invest 29: 770?780","journal-title":"J Clin Invest"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/00365598809180807","volume":"22","author":"P Sj\u00f6str\u00f6m","year":"1988","unstructured":"Sj\u00f6str\u00f6m P, Beermann B, Odlind B (1988) Delayed tolerance to furosemide diuresis. Influence of ACE inhibition by lisinopril. Scand J Urol Nephrol 22: 317?325","journal-title":"Scand J Urol Nephrol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00558227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00558227\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00558227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T06:14:48Z","timestamp":1585980888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00558227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989]]}},"alternative-id":["BF00558227"],"URL":"https:\/\/doi.org\/10.1007\/bf00558227","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989]]}}}